1. Redo-TAVR had low procedural complication rates and was comparable to native-TAVR in terms of risk of death and stroke at 30 days and 1 year. 2. Rates of moderate-to-severe aortic regurgitation were comparable between groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Transcatheter aortic valve replacement (TAVR) has become a standard treatment for aortic
The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued a joint statement in response to the new research on aortic valve replacement in low-risk patients announced during the Transcatheter Cardiovascular Therapeutics Conference, TCT 2023, and recently published in The Annals of Thoracic Surgery.
Study supports minimally invasive procedure as aortic stenosis treatment medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Largest US cardiac database shows excellent long-term survival after surgical aortic valve replacement medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Italy: Exposure to low-dose ropeginterferon alfa-2b (ropeg) is more effective than the standard treatment of phlebotomy and aspirin in patients with low-risk polycythemia vera (PV), a 24-month trial.